Cargando…
Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study
Background Although TNF inhibitors are well established in ankylosing spondylitis treatment, the majority of studies on TNF inhibitors safety have been performed in rheumatoid arthritis patients. Meanwhile, it seems that TNF inhibitors in ankylosing spondylitis may present a better safety profile th...
Autores principales: | Wroński, Jakub, Fiedor, Piotr, Głuszko, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677866/ https://www.ncbi.nlm.nih.gov/pubmed/31172410 http://dx.doi.org/10.1007/s11096-019-00859-7 |
Ejemplares similares
-
Trabecular Bone Score (TBS) in Patients with Early Ankylosing Spondylitis—Limited Utility
por: Nowakowska-Płaza, Anna, et al.
Publicado: (2021) -
Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Ciechomska, Marzena, et al.
Publicado: (2018) -
Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors
por: Wielińska, Joanna, et al.
Publicado: (2021) -
Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis
por: Bonek, Krzysztof, et al.
Publicado: (2022) -
Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)